Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217561 · ClinicalTrials.gov registry record · NA
Testing "Doula Link", a Multi-Component Intervention to Improve Perinatal Mental Health
A NA study of Perinatal Depression and Perinatal Anxiety, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT07217561: Recruiting NA study of Perinatal Depression and Perinatal Anxiety, sponsored by Beth Israel Deaconess Medical Center.
NCT07217561 is a NA study of Perinatal Depression and Perinatal Anxiety that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 90 participants, below the 472-participant average among 12 other Perinatal Depression trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07217561, a NA study of Perinatal Depression and Perinatal Anxiety, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Doulas are trained individuals who offer informational, emotional, and physical support to their pregnant, birthing, and postpartum clients. The goal of this clinical trial is to learn if a new intervention (called "Doula Link") is feasible to implement and acceptable to both doulas and their clients. The main questions it aims to answer are: * Is Doula Link feasible to implement and acceptable to doulas and their clients? * What are the preliminary differences in depression and anxiety between individuals working with doulas who received Doula Link compared to those who did not receive Doula Link? Researchers will compare "Doula Link" to usual doula practice to see if Doula Link is feasible and has potential to improve mental health outcomes in postpartum individuals. Doulas will be randomly assigned to either receive "Doula Link" or continue with their practice as usual. Participating doulas assigned to Doula Link will receive training mental health and implementing an intervention called "Our Babies and Us"; receive access to a toolkit; receive access to perinatal psychiatrists and referral specialists for consultations; receive access to a support group All participating doulas will be invited to complete surveys about their experience with Doula Link (if assigned to that group) and their experience providing care for their clients. All participating clients (pregnant and postpartum individuals) will be invited to complete surveys about their experiences with their doulas, their own mental health, and their experiences with the health system.
Primary Outcome
Perception among postpartum individuals in the Doula Link arm that Doula Link is agreeable and perception among postpartum individuals in the Doula Link arm that Doula Link and its individual components is agreeable. The "Acceptability of Intervention Measure (AIM) will be used. This is a four-question scale scored on a range from 1-5 with higher values indicating better acceptability.
Conditions Studied
Interventions
- BEHAVIORAL Doula Link
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-10-21 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT07217561 shows while recruiting
NCT07217561 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 472-participant average among 12 other Perinatal Depression trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Perinatal Depression appearing as the primary indexed condition, and to 1 intervention - of which Doula Link is the first listed.
NCT07217561 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07217561 about?
NCT07217561 is a clinical study titled "Testing "Doula Link", a Multi-Component Intervention to Improve Perinatal Mental Health". Doulas are trained individuals who offer informational, emotional, and physical support to their pregnant, birthing, and postpartum clients. The goal of this clinical trial is to learn if a new intervention (called "Doula Link") is feasible to implement and acceptable to both doulas and their client...
What is the current status of trial NCT07217561?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-10-21. Estimated completion is 2027-06.
What conditions does trial NCT07217561 study?
This clinical trial studies the following conditions: Perinatal Depression, Perinatal Anxiety.
What interventions are being tested in trial NCT07217561?
The interventions under investigation include: Doula Link (BEHAVIORAL).
Who is sponsoring clinical trial NCT07217561?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07217561 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Perinatal Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07217561's enrollment target sits among peer trials
90 10th of 12 higher than 3 of 12 other Perinatal Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Perinatal Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Acceptability of a Novel Cognitive Behavioral Skills Mobile App for Pregnant and Postpartum Individuals
RECRUITING · NA
-
Maternal Mental Health Access - MaMa
RECRUITING · NA
-
Perinatal Depression and Adverse Childhood Experiences: Prevention Trial
RECRUITING · NA
-
Accelerated TMS for Perinatal Depression
RECRUITING · NA
-
Pathways to Perinatal Mental Health Equity
RECRUITING · NA
-
Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI